These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37171707)

  • 1. Linguistic Analysis of Generic-Generic Drug Name Pairs Prone to Wrong-Drug Errors for which Tall-Man Lettering is Recommended.
    Karet GB
    Ther Innov Regul Sci; 2023 Jul; 57(4):751-758. PubMed ID: 37171707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of 'Tall Man' lettering on errors of visual perception in the recognition of written drug names.
    Darker IT; Gerret D; Filik R; Purdy KJ; Gale AG
    Ergonomics; 2011 Jan; 54(1):21-33. PubMed ID: 21181586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics That May Help in the Identification of Potentially Confusing Proprietary Drug Names.
    Shah MB; Merchant L; Chan IZ; Taylor K
    Ther Innov Regul Sci; 2017 Mar; 51(2):232-236. PubMed ID: 30231718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of tall man lettering on drug name confusion: a laboratory-based investigation in the UK using younger and older adults and healthcare practitioners.
    Filik R; Price J; Darker I; Gerrett D; Purdy K; Gale A
    Drug Saf; 2010 Aug; 33(8):677-87. PubMed ID: 20635826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a list of look-alike drug names with recommended tall man letters.
    Otero López MJ; Martín Muñoz R; Sánchez Barba M; Abad Sazatornil R; Andreu Crespo A; Arteta Jiménez M; Bermejo Vicedo T; Cajaraville Ordoñana G;
    Farm Hosp; 2011; 35(5):225-35. PubMed ID: 21807543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling of medicines and patient safety: evaluating methods of reducing drug name confusion.
    Filik R; Purdy K; Gale A; Gerrett D
    Hum Factors; 2006; 48(1):39-47. PubMed ID: 16696255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic derivation of an Australian standard for Tall Man lettering to distinguish similar drug names.
    Emmerton L; Rizk MF; Bedford G; Lalor D
    J Eval Clin Pract; 2015 Feb; 21(1):85-90. PubMed ID: 25327501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tall man lettering application in medication information systems as a quality and safety strategy in hospital organization.
    Iglesias Gomez R; Font Noguera I; Correa Ballester M; Ruiz Caldes MJ; Poveda Andres JL
    J Clin Pharm Ther; 2022 Oct; 47(10):1570-1575. PubMed ID: 35641241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of different typographical methods on the recognizability of printed drug names.
    Or CK; Wang H
    Drug Saf; 2014 May; 37(5):351-9. PubMed ID: 24718712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The similarity of drug names as a possible cause of confusion: Analysis of data from outpatient care].
    Schrader T; Tetzlaff L; Beck E; Mindt S; Geiss F; Hauser K; Franken C
    Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():29-37. PubMed ID: 32279980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarity as a risk factor in drug-name confusion errors: the look-alike (orthographic) and sound-alike (phonetic) model.
    Lambert BL; Lin SJ; Chang KY; Gandhi SK
    Med Care; 1999 Dec; 37(12):1214-25. PubMed ID: 10599603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of text enhancements on the differentiation performance of orthographically similar drug names.
    Or CK; Chan AH
    Work; 2014; 48(4):521-8. PubMed ID: 24346271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tall Man lettering and potential prescription errors: a time series analysis of 42 children's hospitals in the USA over 9 years.
    Zhong W; Feinstein JA; Patel NS; Dai D; Feudtner C
    BMJ Qual Saf; 2016 Apr; 25(4):233-40. PubMed ID: 26534995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identical or similar brand names used in different countries for medications with different active ingredients: a descriptive analysis.
    Merchant L; Lutter R; Chang S
    BMJ Qual Saf; 2020 Dec; 29(12):988-991. PubMed ID: 32341076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names.
    Bryan R; Aronson JK; ten Hacken P; Williams A; Jordan S
    PLoS One; 2015; 10(12):e0145431. PubMed ID: 26701761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting look-alike and sound-alike medication errors.
    Lambert BL
    Am J Health Syst Pharm; 1997 May; 54(10):1161-71. PubMed ID: 9161623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tall man lettering on the visual behaviour of critical care nurses while identifying syringe drug labels: a randomised in situ simulation.
    Lohmeyer Q; Schiess C; Wendel Garcia PD; Petry H; Strauch E; Dietsche A; Schuepbach RA; Buehler PK; Hofmaenner DA
    BMJ Qual Saf; 2023 Jan; 32(1):26-33. PubMed ID: 35260415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential for using drug indications to prevent look-alike and sound-alike drug errors.
    Seoane-Vazquez E; Rodriguez-Monguio R; Alqahtani S; Schiff G
    Expert Opin Drug Saf; 2017 Oct; 16(10):1103-1109. PubMed ID: 28724335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing safe drug names.
    Lambert BL; Lin SJ; Tan H
    Drug Saf; 2005; 28(6):495-512. PubMed ID: 15924503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tallman lettering as a strategy for differentiation in look-alike, sound-alike drug names: the role of familiarity in differentiating drug doppelgangers.
    DeHenau C; Becker MW; Bello NM; Liu S; Bix L
    Appl Ergon; 2016 Jan; 52():77-84. PubMed ID: 26360197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.